Patient characteristics | N = 756 |
Age at start of first-line therapy (years) |
|
Mean (SD) | 60.8 (12.6) |
Median | 61.2 |
Range (minimum - maximum) | 26.2 - 93.3 |
Age at start of first-line therapy, n (%) |
|
≥18 - <50 years | 156 (20.6) |
≥50 - <65 years | 304 (40.2) |
≥65 years | 296 (39.2) |
Gender, n (%) |
|
Male | 418 (55.3) |
Female | 338 (44.7) |
Diagnosis, n (%) |
|
Colon | 583 (77.1) |
Rectal | 172 (22.8) |
Both | 1 (0.1) |
Body Mass Index, n (%) |
|
Normal | 328 (43.4) |
Overweight | 255 (33.7) |
Obese | 173 (22.9) |
ECOG at index date 1, n (%) of 756 1L patients |
|
0 | 161 (21.3) |
1 | 488 (64.6) |
≥2 | 85 (11.2) |
Unknown | 22 (2.9) |
ECOG at index date 2, n (%) of 743 2L patients |
|
0 | 112 (15.1) |
1 | 510 (68.6) |
≥2 | 99 (13.3) |
Unknown | 22 (2.9) |
ECOG at index date 3, n (%) of 577 3L patients |
|
0 | 58 (10.1) |
1 | 396 (68.6) |
≥2 | 106 (18.4) |
Unknown | 17 (3.0) |
Metastasis location at start of first-line therapy, n (%) |
|
Liver only | 214 (28.3) |
Lung only | 24 (3.2) |
Bone, ovary, peritoneum, or retroperitoneum only | 20 (2.6) |